Phone app could revolutionize MS monitoring

NCT ID NCT05009160

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether smartphone-based challenges and surveys can reliably measure multiple sclerosis (MS) progression. Researchers will compare these digital biomarkers with standard clinical exams, brain scans, and lab tests in 300 people with MS over two years. The goal is to develop more frequent, convenient, and sensitive ways to track the disease and guide treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centro Sclerosi Multipla, Ospedale Regionale di Lugano

    Lugano, Switzerland, Switzerland

  • Department of Neurology, CHUV Lausanne

    Lausanne, Switzerland, Switzerland

  • Klinik für Neurologie, Kantonsspital St. Gallen

    Sankt Gallen, Switzerland, Switzerland

  • Klinik für Neurologie, Universitätsspital Zürich

    Zurich, Switzerland, Switzerland

  • MS Center, Department of Neurology University Hospital Basel

    Basel, Switzerland

  • Neurozentrum, Kantonsspital Aarau

    Aarau, Switzerland, Switzerland